Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Immunol. 2014 May;14(5):349. doi: 10.1038/nri3401-c1.

IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist.

Author information

1
1] Institute of Pharmacology, University of Bern, CH-3010 Bern, Switzerland. [2].
2
1] Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Aviv University, Tel Aviv 5262225, Israel. Yehuda Shoenfeld is also at the Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel Aviv University, Tel Aviv 5262225, Israel. [2].
3
1] Department of Medicine, University of Toronto, and Centre for Innovation, Canadian Blood Services, Toronto, Ontario M5G 2M1, Canada. [2].
4
1] Department of Immunology, Stefan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Sofia 1113, Bulgaria. [2].
5
1] Research and Development, CSL Behring AG, CH-3000 Bern, Switzerland. [2].
6
1] Institut National de la Santé et de la Recherche Médicale, Paris, France; Université Pierre et Marie Curie, Paris 6, Centre de Recherche des Cordeliers, 75006 Paris, France. [2].
PMID:
24762829
DOI:
10.1038/nri3401-c1
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center